STOCKHOLM, Sweden, Feb. 2, 2005 (PRIMEZONE) -- During the period January 19 through February 1, 2005, Elekta has repurchased 224,900 B shares at an average price of SEK 222.34, totaling SEK 50,005,161.
Accordingly, Elekta's current holding of own shares (treasury stock) amounts to 224,900 B shares, which will be cancelled.
These repurchases were carried out in line with the Board's decision on December 14, 2004, to fulfill the company's dividend policy through the repurchase of shares amounting to SEK 50 M, corresponding to 20 percent of net profit in the 2003/04 fiscal year.
The total number of shares in Elekta (prior to cancellation of the shares now repurchased) amounts to 31,567,454. Additional repurchases require decision of the Elekta Board of Directors.
For further information, please contact: United States: Lars Jonsteg, VP Investor Relations North America Tel: +46 708-783 735 e-mail: lars.jonsteg@elekta.com International: Peter Ejemyr, Group VP Corporate Communications Tel: +46 733 611 000 e-mail: peter.ejemyr@elekta.com
Elekta is a world-leading supplier of advanced and innovative radiation oncology and neurosurgery solutions and services for precise treatment of cancer and brain disorders. Elekta's solutions are clinically effective, cost efficient and gentle to the patient.
For additional information about Elekta, please visit www.elekta.com
This information was brought to you by Waymaker.
The following files are available for download:
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=68781&fn=wkr0001.pdf PDF Version
-0-